Shamburg News · 8-K filed Nov 18, 2026, 10:06 AM EST

Impact BioMedical Completes Business Combination with Dr Ashleys Limited; Shares Delisted from NYSE American

IBO · IMPACT BIOMEDICAL INC.

  • Acquisition
  • Delisting
  • Leadership change
  • Other event
  • Materiality: high

On November 17, 2026, Impact BioMedical Inc. completed its merger with Merger Sub and a share exchange with PubCo and the Zoar Shareholder, making the company a wholly-owned subsidiary of PubCo. Company common stock was converted into 8,640,000 PubCo ordinary shares, representing approximately 4.80% of PubCo's outstanding shares at closing, following a 1-for-12.62 reverse split. The company requested NYSE American suspend trading and withdraw its listing, and it intends to file Form 15 to deregister its common stock; the board and CFO/COO resigned and new PubCo directors and officers were appointed.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, accession 0001493152-26-053017.

Written from the filing by Shamburg Markets. Figures are as reported by the company.